The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of bone modifying agents in patients with metastatic castrate-sensitive prostate cancer.
 
Aaron Philip Mitchell
No Relationships to Disclose
 
Akriti A. Mishra
No Relationships to Disclose
 
Peter B Bach
Leadership - Oncology Analytics
Stock and Other Ownership Interests - EQRx; Grail; Oncology Analytics
Honoraria - American Osteopathic Association; Cello Health; Defined Health; Foundation Medicine; Grail; Mercer; Morgan Stanley; Oncology Analytics; Oppenheimer; United Rheumatology
Consulting or Advisory Role - GRAIL
Research Funding - Kaiser Permanente; Laura and John Arnold Foundation; NIH
Travel, Accommodations, Expenses - Commonwealth Fund; JP Morgan; Magellan Health; Morgan Stanley; Oncology Analytics; United Rheumatology; Washington Post
 
Michael J. Morris
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bayer; Curium Pharma; Curium Pharma; Endocyte; Johnson & Johnson; ORIC Pharmaceuticals
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Janssen (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Endocyte; Fujifilm